LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (3)
Two Sigma
$92.5M
added
Squarepoint
$40.5M
added
Point72
$37.1M
bought
No tracked top-trader positions in ARGX as of Oct 24, 09:33 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Oct 22, 2026
Period ending
Sep 30, 2026
Earnings per share
-$27.83 expected
Revenue
Yahoo Finance
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 22, 2026 | $7.80 / -$27.83Yahoo Finance | +128.03% beat | $1.75B No estimate | Unavailable |
| Jun 30, 2026 | Jul 23, 2026 | $7.32 / $6.19Yahoo Finance | +18.17% beat | $2.82B No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $5.52 / $4.92Yahoo Finance | +12.12% beat | $1.30B No estimate | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | $8.02 / $6.11Yahoo Finance | +31.24% beat | $3.21B No estimate | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $5.18 / $4.16Alpha Vantage | +24.52% beat | $1.13B No estimate | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $3.74 / $3.02Alpha Vantage | +23.84% beat | $948.0M No estimate | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $2.58 / $2.31Alpha Vantage | +11.69% beat | $790.7M No estimate | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | $0.71 / $1.70Alpha Vantage | -58.04% miss | $1.35B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.13B | $3.21B | $1.30B | $2.82B |
| Cost of what it sold | $109.4M | $339.9M | $121.0M | $279.3M |
| Gross profit | $1.02B | $2.87B | $1.18B | $2.54B |
| What it spent | ||||
| Research and development | $355.7M | $443.0M | $443.0M | $486.0M |
| Sales and admin | $336.3M | $422.5M | $355.0M | $532.5M |
| Other operating costs | $85.0M | $1.15B | $106.0M | $671.1M |
| Total operating expenses | $777.0M | $2.01B | $904.0M | $1.69B |
| What was left | ||||
| Operating profit | $350.0M | $850.8M | $394.0M | $846.8M |
| Interest on debt | $993.0K | $1.0M | $1.0M | $2.0M |
| Profit before tax | $386.1M | $991.7M | $426.0M | $958.9M |
| Tax | — | -$55.0M | — | $119.1M |
| Net profit | $344.3M | $1.05B | $366.0M | $838.8M |
| EBITDA | $387.0M | $1.01B | $427.0M | $863.8M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
[argenx SE Q3 2026 Earnings Call] argenx Posts $1.7B in Q3 Sales, Up 54%, as Seronegative MG 'Halo Effect' Surprises Management; Eyes Five U.S. Launches in 2027
BullishOct 22Sales reach $1.72B at argenx (ARGX) as Q3 profit climbs.
BullishOct 22Argenx stock: Argenx gains 5.41 percent in the session
BullishOct 20Argenx stock surges 5% following Oddo BHF price target increase
BullishOct 20argenx SE Stock (ARGX) Moved Up by 5.99% on Oct 20: What Signal Does It Send?
Leans bullishOct 20argenx sets October 22 results date for argenx stock
NeutralOct 19Oppenheimer cuts target to USD 1,038 for Argenx stock
NeutralOct 14Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
NeutralOct 12
